MARKET

SSKN

SSKN

STRATA Skin
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.410
+0.015
+1.08%
Closed 16:00 09/25 EDT
OPEN
1.380
PREV CLOSE
1.395
HIGH
1.460
LOW
1.380
VOLUME
22.34K
TURNOVER
--
52 WEEK HIGH
2.840
52 WEEK LOW
0.7520
MARKET CAP
47.59M
P/E (TTM)
-11.4821
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
STRATA Skin Sciences Announces New Recurring Revenue Direct Distribution Contract with JMEC Co., Ltd. in Japan
Company expanding global presence and introducing recurring business model in JapanHORSHAM, Pa., Sept. 14, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN)  (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing
GlobeNewswire · 09/14 13:00
STRATA Skin Sciences to Present at Two Upcoming Investor Conferences
GlobeNewswire · 09/08 13:00
Healthcare - Top 5 Gainers / Losers
Gainers: Aduro Biotech (ADRO) +20%. Otonomy (OTIC) +14%. BeyondSpring (BYSI) +13%. Verrica Pharmaceuticals (VRCA) +13%. STRATA Skin Sciences (SSKN) +11%.Losers: Poseida Therapeutics (PSTX) -30%. Acer Therapeutics (ACER) -20%. Biofrontera (BFRA) -15%. Unity Biotechnology
Seekingalpha · 08/18 15:02
Strata Skin Sciences shares are trading lower after the company reported worse-than-expected Q2 EPS and sales results.
Benzinga · 08/11 12:31
The Daily Biotech Pulse: Regulatory Setback For Fennec Pharma, Ligand To Buy Pfenex, Inovio Says Phase 2/3 Coronavirus Vaccine Study Starts In September
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10)
Benzinga · 08/11 12:20
Strata Skin Sciences Q2 EPS $(0.05) Misses $(0.03) Estimate, Sales $4.03M Miss $5.13M Estimate
Strata Skin Sciences (NASDAQ:SSKN) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.03) by 66.67 percent. This is a 66.67 percent decrease over losses of $(0.03) per share
Benzinga · 08/11 12:06
Strata Skin Sciences Q2 EPS $(0.05) Misses $(0.03) Estimate, Sales $4.03M Miss $5.13M Estimate
Strata Skin Sciences (NASDAQ:SSKN) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.03) by 66.67 percent. This is a 66.67 percent decrease over losses of $(0.03) per share
Benzinga · 08/11 12:06
STRATA Skin Sciences to Host Second Quarter 2020 Financial Results and Business Update Conference Call on August 11
HORSHAM, Pa., Aug. 04, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products f
GlobeNewswire · 08/04 12:00
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SSKN. Analyze the recent business situations of STRATA Skin through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SSKN stock price target is 4.875 with a high estimate of 6.00 and a low estimate of 3.750.
EPS
Institutional Holdings
Institutions: 38
Institutional Holdings: 11.09M
% Owned: 32.86%
Shares Outstanding: 33.75M
TypeInstitutionsShares
Increased
5
1.56M
New
12
-69.56K
Decreased
1
3
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.83%
Healthcare Equipment & Supplies
+2.01%
Key Executives
Chairman/Director
LuAnn Via
President/Director
Frank McCaney
Chief Executive Officer
Dolev Rafaeli
Chief Financial Officer
Matthew Hill
Director
James Coyne
Director
Jeffrey O'Donnell
Independent Director
Samuel Navarro
Independent Director
David Stone
Independent Director
Kathryn Swintek
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About SSKN
STRATA Skin Sciences, Inc., formerly MELA Sciences, Inc., is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging. The XTRAC and VTRAC products are the devices used for the treatment of psoriasis, vitiligo and other skin disorders. The XTRAC system delivers targeted ultraviolet light to affected areas of skin, leading to psoriasis clearing and vitiligo repigmentation, following a series of treatments. The Company's technology includes XTRAC Excimer Laser, VTRAC Lamp and MelaFind. MelaFind is a non-invasive, point-of-care instrument to aid dermatologists in their decision to biopsy suspicious pigmented lesions, such as melanoma. The Company has approximately two distribution channels for phototherapy treatment equipment.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of STRATA Skin Sciences Inc stock information, including NASDAQ:SSKN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SSKN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SSKN stock methods without spending real money on the virtual paper trading platform.